| Hang Seng Index | 26.380 HKD | +0.540 | +2.090% | 382.96M | 10.08B | 25.859 (+2.017%) HKD as at 2025/08/22 | | |
| Hang Seng China Enterprises | 94.760 HKD | +1.920 | +2.068% | 100.23M | 9.47B | 91.830 (+3.190%) HKD as at 2025/08/21 | | |
| Hang Seng TECH Index | 5.725 HKD | +0.185 | +3.339% | 1.27B | 7.26B | 5.547 (+3.218%) HKD as at 2025/08/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 6.075 HKD | +0.395 | +6.954% | 312.38M | 1.87B | 5.710 (+6.392%) HKD as at 2025/08/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.388 HKD | -0.104 | -6.971% | 725.42M | 1.02B | 1.487 (-6.664%) HKD as at 2025/08/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.878 HKD | -0.088 | -4.476% | 266.20M | 503.41M | 1.963 (-4.335%) HKD as at 2025/08/22 | | |
| Hang Seng TECH Index | 12.290 HKD | +0.420 | +3.538% | 32.83M | 401.47M | 11.587 (+6.067%) HKD as at 2025/08/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 6.085 HKD | +0.255 | +4.374% | 64.22M | 387.91M | 5.843 (+4.147%) HKD as at 2025/08/22 | | |
| Hang Seng TECH Index | 5.815 HKD | +0.185 | +3.286% | 62.11M | 359.29M | 5.484 (+6.034%) HKD as at 2025/08/21 | | |
| CSI 300 | 50.380 HKD | +0.840 | +1.696% | 5.18M | 259.60M | 49.260 (+2.274%) HKD as at 2025/08/22 | | |
| CSI Hong Kong Dividend | 37.660 HKD | +0.300 | +0.803% | 5.14M | 194.01M | 37.655 (+0.015%) HKD as at 2025/08/22 | | |
| FTSE China A50 | 15.980 HKD | +0.260 | +1.654% | 11.84M | 188.48M | 15.375 (+3.933%) HKD as at 2025/08/21 | | |
| Hang Seng China Enterprises | 10.830 HKD | +0.060 | +0.557% | 16.00M | 173.23M | 10.673 (+1.475%) HKD as at 2025/08/21 | | |
| FTSE China A50 | 14.880 HKD | +0.240 | +1.639% | 8.34M | 123.54M | 14.592 (+1.971%) HKD as at 2025/08/22 | | |
| London Gold Fixing Price | 2,421.000 HKD | +20.000 | +0.833% | 47.57K | 115.04M | N/A | | |
| SSE Science and Technology Innovation Board 50 Index | 11.760 HKD | +0.150 | +1.292% | 4.16M | 49.40M | 11.481 (+2.431%) HKD as at 2025/08/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 6.150 HKD | +0.350 | +6.034% | 6.85M | 41.09M | 5.387 (+14.172%) HKD as at 2025/08/21 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 13.800 HKD | -0.120 | -0.862% | 2.84M | 39.42M | 13.914 (-0.821%) HKD as at 2025/08/22 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 11.170 HKD | +0.820 | +7.923% | 2.79M | 31.56M | 10.327 (+8.161%) HKD as at 2025/08/22 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 17.550 HKD | +0.030 | +0.171% | 1.32M | 23.21M | 17.587 (-0.208%) HKD as at 2025/08/22 | | |
| CSI 300 | 33.120 HKD | +0.720 | +2.222% | 700.80K | 23.06M | 31.597 (+4.820%) HKD as at 2025/08/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.642 HKD | +0.134 | +2.972% | 4.97M | 22.90M | 4.476 (+3.704%) HKD as at 2025/08/22 | | |
| MSCI Asia APEX 50 | 66.180 HKD | +1.160 | +1.784% | 341.75K | 22.59M | 65.006 (+1.806%) HKD as at 2025/08/21 | | |
| FactSet China Robotics and Artificial Intelligence Index (net total return) | 54.660 HKD | +0.760 | +1.410% | 397.60K | 21.62M | 51.896 (+5.326%) HKD as at 2025/08/21 | | |
| ChiNext Index | 10.650 HKD | +0.320 | +3.098% | 1.68M | 17.76M | 10.242 (+3.988%) HKD as at 2025/08/22 | | |
| Hang Seng TECH Index | 7.440 HKD | +0.265 | +3.693% | 2.30M | 16.94M | 7.194 (+3.417%) HKD as at 2025/08/22 | | |
| FTSE China A50 | 14.630 CNY | +0.170 | +1.176% | 1.15M | 16.81M | 14.135 (+3.503%) CNY as at 2025/08/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.758 HKD | -0.126 | -3.244% | 4.29M | 16.16M | 3.872 (-2.942%) HKD as at 2025/08/21 | | |
| FactSet China Semiconductor Index (net total return) | 51.500 HKD | +0.680 | +1.338% | 288.85K | 14.86M | 46.990 (+9.597%) HKD as at 2025/08/21 | | |
| Hang Seng High Dividend Yield | 30.680 HKD | +0.180 | +0.590% | 472.70K | 14.51M | 30.443 (+0.778%) HKD as at 2025/08/21 | | |